{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:06:21Z","timestamp":1792551981817,"version":"4.5.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae223","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T17:53:14Z","timestamp":1712253194000},"page":"e276-e282","source":"Crossref","is-referenced-by-count":4,"title":["Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis"],"prefix":"10.1210","volume":"110","author":[{"given":"Xiaowen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacy, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Shing","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]},{"name":"Department of Medicine, The University of Hong Kong-Shenzhen Hospital , Shenzhen 518053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Yi","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]},{"name":"State Key Laboratory of Liver Research, The University of Hong Kong , Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C B","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie W C","family":"Kung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi-Kei","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]},{"name":"Laboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park , Pak Shek Kok, Hong Kong Special Administrative Region ,","place":["China"]},{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London , London WC1N 1AX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-9144","authenticated-orcid":false,"given":"Ching-Lung","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]},{"name":"Laboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park , Pak Shek Kok, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"5","key":"2025012110285342700_dgae223-B1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"10308","key":"2025012110285342700_dgae223-B2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"2025012110285342700_dgae223-B3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"2025012110285342700_dgae223-B4","first-page":"85","article-title":"The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"2025012110285342700_dgae223-B5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab"},{"issue":"2","key":"2025012110285342700_dgae223-B6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"2025012110285342700_dgae223-B7","doi-asserted-by":"crossref","first-page":"100752","DOI":"10.1016\/j.jbior.2020.100752","article-title":"The roles of osteocalcin in lipid metabolism in adipose tissue and liver","volume":"78","author":"Otani","year":"2020","journal-title":"Adv Biol Regul"},{"issue":"3","key":"2025012110285342700_dgae223-B8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-5491.2012.03769.x","article-title":"Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese","volume":"30","author":"Chen","year":"2013","journal-title":"Diabet Med"},{"issue":"2","key":"2025012110285342700_dgae223-B9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0169-6009(90)90113-T","article-title":"Decreased serum osteocalcin levels in patients with liver cirrhosis","volume":"8","author":"Pietschmann","year":"1990","journal-title":"Bone Miner"},{"issue":"4","key":"2025012110285342700_dgae223-B10","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jbmr.4227","article-title":"Osteocalcin and non-alcoholic fatty liver disease: lessons from two population-based cohorts and animal models","volume":"36","author":"Xia","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2025012110285342700_dgae223-B11","doi-asserted-by":"crossref","first-page":"107941","DOI":"10.1016\/j.pharmthera.2021.107941","article-title":"The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and\/or biological target for the treatment of fibrotic diseases","volume":"228","author":"Habibie","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"5","key":"2025012110285342700_dgae223-B12","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3892\/etm.2016.3754","article-title":"Concentrations of fetuin-A, osteoprotegerin and \u03b1-Klotho in patients with alcoholic liver cirrhosis","volume":"12","author":"Prystupa","year":"2016","journal-title":"Exp Ther Med"},{"issue":"4","key":"2025012110285342700_dgae223-B13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1478-3231.2007.01448.x","article-title":"Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease","volume":"27","author":"Monegal","year":"2007","journal-title":"Liver Int"},{"issue":"6","key":"2025012110285342700_dgae223-B14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","article-title":"The RANKL\/OPG system and bone mineral density in patients with chronic liver disease","volume":"43","author":"Moschen","year":"2005","journal-title":"J Hepatol"},{"issue":"9","key":"2025012110285342700_dgae223-B15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"issue":"4","key":"2025012110285342700_dgae223-B16","doi-asserted-by":"crossref","first-page":"e35612","DOI":"10.1371\/journal.pone.0035612","article-title":"The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease","volume":"7","author":"Patouraux","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"2025012110285342700_dgae223-B17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1742-1241.2007.01368.x","article-title":"Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection","volume":"62","author":"Zhao","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2025012110285342700_dgae223-B18","doi-asserted-by":"crossref","first-page":"e0118744","DOI":"10.1371\/journal.pone.0118744","article-title":"Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection","volume":"10","author":"Matsue","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2025012110285342700_dgae223-B19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cld.498","article-title":"Bone disease in cirrhosis","volume":"6","author":"Patel","year":"2015","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"28","key":"2025012110285342700_dgae223-B20","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.3748\/wjg.v20.i28.9427","article-title":"Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications","volume":"20","author":"Nakchbandi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"2025012110285342700_dgae223-B21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v3.i12.300","article-title":"Hepatic osteodystrophy: an important matter for consideration in chronic liver disease","volume":"3","author":"L\u00f3pez-Larramona","year":"2011","journal-title":"World J Hepatol"},{"issue":"2","key":"2025012110285342700_dgae223-B22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ije\/dyx172","article-title":"Cohort profile: the Hong Kong osteoporosis study and the follow-up study","volume":"47","author":"Cheung","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"8","key":"2025012110285342700_dgae223-B23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jbmr.3448","article-title":"Association of alendronate and risk of cardiovascular events in patients with hip fracture","volume":"33","author":"Sing","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2025012110285342700_dgae223-B24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"issue":"44","key":"2025012110285342700_dgae223-B25","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.3748\/wjg.v23.i44.7863","article-title":"Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis","volume":"23","author":"Cheung","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2025012110285342700_dgae223-B26","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"2025012110285342700_dgae223-B27","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182688d2f","article-title":"Use of administrative claims data for identifying patients with cirrhosis","volume":"47","author":"Nehra","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"2025012110285342700_dgae223-B28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pds.2148","article-title":"Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study","volume":"20","author":"Lo Re","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025012110285342700_dgae223-B29","author":"Zhang"},{"issue":"9403","key":"2025012110285342700_dgae223-B30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"2025012110285342700_dgae223-B31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s40618-016-0528-3","article-title":"Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults","volume":"39","author":"Lee","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2025012110285342700_dgae223-B32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/13697137.2018.1481380","article-title":"Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women","volume":"21","author":"Lee","year":"2018","journal-title":"Climacteric"},{"issue":"12","key":"2025012110285342700_dgae223-B33","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1210\/jc.2009-0835","article-title":"Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis","volume":"94","author":"Gonz\u00e1lez-Calvin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025012110285342700_dgae223-B34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/jcem-70-4-1202","article-title":"The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men","volume":"70","author":"Orwoll","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025012110285342700_dgae223-B35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00198-019-04975-y","article-title":"Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study","volume":"30","author":"Leslie","year":"2019","journal-title":"Osteoporos Int"},{"issue":"15","key":"2025012110285342700_dgae223-B36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archinte.167.15.1641","article-title":"Single-Site vs multisite bone density measurement for fracture prediction","volume":"167","author":"Leslie","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"2025012110285342700_dgae223-B37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00268-019-05206-5","article-title":"Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma","volume":"44","author":"Toshima","year":"2020","journal-title":"World J Surg"},{"issue":"1","key":"2025012110285342700_dgae223-B38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12876-023-02835-y","article-title":"Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study","volume":"23","author":"Saeki","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"2025012110285342700_dgae223-B39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/ijbs.16445","article-title":"Role of osteopontin in liver diseases","volume":"12","author":"Wen","year":"2016","journal-title":"Int J Biol Sci"},{"issue":"2","key":"2025012110285342700_dgae223-B40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling","volume":"55","author":"Urtasun","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"2025012110285342700_dgae223-B41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1478-3231.2005.01073.x","article-title":"Osteoprotegerin and RANKL in alcoholic liver cirrhosis","volume":"25","author":"F\u00e1brega","year":"2005","journal-title":"Liver Int"},{"issue":"3","key":"2025012110285342700_dgae223-B42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/alcalc\/agl004","article-title":"Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease","volume":"41","author":"Garc\u00eda-Valdecasas-Campelo","year":"2006","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"2025012110285342700_dgae223-B43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-014-0154-x","article-title":"Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA","volume":"12","author":"Cheung","year":"2014","journal-title":"BMC Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae223\/57320276\/dgae223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/2\/e276\/57320276\/dgae223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/2\/e276\/57320276\/dgae223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T10:29:59Z","timestamp":1737455399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/2\/e276\/7640943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,4]]},"published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae223","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,4,4]]}}}